Intech Investment Management LLC Purchases 2,430 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Intech Investment Management LLC boosted its holdings in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 25.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 12,070 shares of the biotechnology company's stock after buying an additional 2,430 shares during the period. Intech Investment Management LLC's holdings in Axon Enterprise were worth $7,173,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Public Sector Pension Investment Board increased its position in shares of Axon Enterprise by 19.2% in the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company's stock worth $1,240,000 after purchasing an additional 500 shares during the last quarter. CIBC Asset Management Inc increased its holdings in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company's stock worth $4,227,000 after buying an additional 895 shares during the last quarter. Soros Capital Management LLC bought a new stake in shares of Axon Enterprise during the 3rd quarter worth $630,000. Friedenthal Financial grew its position in Axon Enterprise by 961.7% in the fourth quarter. Friedenthal Financial now owns 1,359 shares of the biotechnology company's stock worth $808,000 after acquiring an additional 1,231 shares in the last quarter. Finally, Principal Financial Group Inc. increased its stake in Axon Enterprise by 33.1% in the third quarter. Principal Financial Group Inc. now owns 136,302 shares of the biotechnology company's stock valued at $54,466,000 after acquiring an additional 33,869 shares during the last quarter. 79.08% of the stock is currently owned by institutional investors.

Remove Ads

Insiders Place Their Bets

In other news, insider Jeffrey C. Kunins sold 1,035 shares of Axon Enterprise stock in a transaction that occurred on Monday, December 23rd. The shares were sold at an average price of $624.47, for a total transaction of $646,326.45. Following the completion of the transaction, the insider now directly owns 124,243 shares in the company, valued at approximately $77,586,026.21. This trade represents a 0.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm's stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the transaction, the director now directly owns 6,929 shares of the company's stock, valued at approximately $4,185,601.03. This trade represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,792 shares of company stock worth $1,087,843. Company insiders own 5.70% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on AXON. Needham & Company LLC reiterated a "buy" rating and set a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday, February 26th. JMP Securities reissued an "outperform" rating on shares of Axon Enterprise in a research note on Tuesday, February 4th. The Goldman Sachs Group upped their price objective on shares of Axon Enterprise from $500.00 to $700.00 and gave the company a "buy" rating in a research note on Monday, January 27th. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Finally, Northcoast Research cut Axon Enterprise from a "buy" rating to a "neutral" rating in a research note on Wednesday, February 19th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and an average price target of $604.67.

Axon Enterprise Trading Up 0.3 %

Shares of Axon Enterprise stock traded up $1.59 during midday trading on Friday, reaching $560.00. 802,214 shares of the company's stock traded hands, compared to its average volume of 845,276. The stock has a 50 day moving average of $591.90 and a 200-day moving average of $542.26. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a market cap of $42.91 billion, a PE ratio of 144.70, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.